OpinionViewpoints

Is Paxlovid a Dud?

Save
Is Paxlovid a Dud?
Tero Vesalainen/Shutterstock
Maryanne Demasi
Updated:
0:00
Commentary

Of all the antiviral drugs for COVID-19, Pfizer’s Paxlovid has been the most successful. Not for its safety and efficacy, but for its ability to earn the company billions in profits despite being largely ineffective for most people.

Maryanne Demasi
Maryanne Demasi
PhD
Maryanne Demasi is an investigative medical reporter with a doctorate in rheumatology, who writes for online media and top tiered medical journals. For over a decade, Ms. Demasi produced TV documentaries for the ABC and has worked as a speechwriter and political advisor for the South Australian Science Minister. Her work can be accessed on: MaryanneDemasi.Substack.com
twitter